Prenetics’ IM8 Reports Q2 2026 Revenue Growth of 288% YoY; Raises FY 2026 IM8 Revenue Guidance to $220–230 Million; July Was the First Month of Positive Consolidated Adjusted Free Cash Flow and Expected to Remain Positive for Q3 and Beyond
Total revenue of $46.5 million, up ~288% YoY (~3.9x); within the Company’s guidance of $46-48 million IM8 revenue of $45.0 million, up ~359% YoY (~4.6x); within the Company’s guidance of $44-46 million, marking the sixth consecutive record quarter July: strongest month ever at IM8 with $20.9 million — $251 million annualized revenue run-rate Initiates FY2027 … Read more